Unknown

Dataset Information

0

Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling.


ABSTRACT: Activation of aldosterone/mineralocorticoid receptors (MR) has been implicated in vascular dysfunction of diabetes. Underlying mechanisms are elusive. Therefore, we investigated the role of Rho kinase (ROCK) in aldosterone/MR signaling and vascular dysfunction in a model of diabetes. Diabetic obese mice (db/db) and control counterparts (db/+) were treated with MR antagonist (MRA, potassium canrenoate, 30?mg/kg/day, 4 weeks) or ROCK inhibitor, fasudil (30?mg/kg/day, 3 weeks). Plasma aldosterone was increased in db/db versus db/+. This was associated with enhanced vascular MR signaling. Norepinephrine (NE)-induced contraction was increased in arteries from db/db mice. These responses were attenuated in mice treated with canrenoate or fasudil. Db/db mice displayed hypertrophic remodeling and increased arterial stiffness, improved by MR blockade. Vascular calcium sensitivity was similar between depolarized arteries from db/+ and db/db. Vascular hypercontractility in db/db mice was associated with increased myosin light chain phosphorylation and reduced expression of PKG-1?. Vascular RhoA/ROCK signaling and expression of pro-inflammatory and pro-fibrotic markers were exaggerated in db/db mice, effects that were attenuated by MRA. Fasudil, but not MRA, improved vascular insulin sensitivity in db/db mice, evidenced by normalization of Irs1 phosphorylation. Our data identify novel pathways involving MR-RhoA/ROCK-PKG-1 that underlie vascular dysfunction and injury in diabetic mice.

SUBMITTER: Nguyen Dinh Cat A 

PROVIDER: S-EPMC5811612 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling.

Nguyen Dinh Cat Aurelie A   Callera Glaucia E GE   Friederich-Persson Malou M   Sanchez Ana A   Dulak-Lis Maria Gabriela MG   Tsiropoulou Sofia S   Montezano Augusto C AC   He Ying Y   Briones Ana M AM   Jaisser Frederic F   Touyz Rhian M RM  

Scientific reports 20180213 1


Activation of aldosterone/mineralocorticoid receptors (MR) has been implicated in vascular dysfunction of diabetes. Underlying mechanisms are elusive. Therefore, we investigated the role of Rho kinase (ROCK) in aldosterone/MR signaling and vascular dysfunction in a model of diabetes. Diabetic obese mice (db/db) and control counterparts (db/+) were treated with MR antagonist (MRA, potassium canrenoate, 30 mg/kg/day, 4 weeks) or ROCK inhibitor, fasudil (30 mg/kg/day, 3 weeks). Plasma aldosterone w  ...[more]

Similar Datasets

| S-EPMC2451047 | biostudies-other
| S-EPMC5446265 | biostudies-literature
| S-EPMC6761027 | biostudies-literature
| S-EPMC9889365 | biostudies-literature
| S-EPMC3951242 | biostudies-literature
| S-EPMC1162842 | biostudies-other
| S-EPMC4290036 | biostudies-literature
| S-EPMC4446717 | biostudies-literature
| S-EPMC6626623 | biostudies-literature
| S-EPMC4245833 | biostudies-literature